WebDr. Torbjørn Bjerke, MD, is a Chairman at SynAct Pharma AB and a Portfolio Manager at Arctic Asset Management AS. He is on the Board of Directors at Biothea Pharma, Inc. At Arctic he has the responsibility of scientific, clinical and regulatory due dilligence of new opportunities and portfolio management and has more than 30 years of executive ... WebAug 5, 2024 · Biothea Pharma General Information. Description. Developer of needle-free treatments intended for severe allergic reactions and anaphylaxis. The company is …
Biothea Pharma Company Profile: Valuation & Investors
WebMedical. Pharmaceutical. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2015. Founders John F. Vavricka. Operating Status Active. … WebAug 12, 2016 · A couple who say that a company has registered their home as the position of more than 600 million IP addresses are suing the company for $75,000. James and … how fast is 10 knots in miles per hour
Biothea Pharma - Products, Competitors, Financials, …
WebJohn Vavricka has served as our Chief Commercial Officer since October 2024. Prior to joining us, Mr. Vavricka cofounded Biothea Pharma, Inc., a biotechnology company, in 2015, and also served as the Founder, Chief Executive Officer and President of Iroko Pharmaceuticals, Inc., a global pharmaceuticals company, from 2007 to 2015. Mr. WebBiothea Pharma's headquarters is located at 125 Summer Street, Boston. What is Biothea Pharma's latest funding round? Biothea Pharma's latest funding round is Series A. How much did Biothea Pharma raise? Biothea Pharma raised a total of $22M. Who are the investors of Biothea Pharma? WebI. Biography of Jean-Pierre Sommadossi. Dr. Jean-Pierre Sommadossi is a Chairman at Kezar Life Sciences, Inc., a Chairman, President & Chief Executive Officer at Atea Pharmaceuticals, Inc., a Member-Discovery Council at Harvard Medical School and an Independent Director at ABG Acquisition Corp. I. He is on the Board of Directors at … high emissivity coating